Bausch Health Companies Inc. Common Stock Dividends Paid
Bausch Health Companies Inc. (BHC) reported Common Stock Dividends Paid of $0 for the 3-month period ending 2011-06-30, per its 10-Q filed 2011-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividendsCommonStock · last filed 2013-02-28
- Bausch Health Companies Inc. payments of ordinary dividends, common stock for the quarter ending 2011-06-30 was $0.00, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. payments of ordinary dividends, common stock for the quarter ending 2010-12-31 was $312.73M, a 2095.49% increase year-over-year.
- Bausch Health Companies Inc. payments of ordinary dividends, common stock for the quarter ending 2010-09-30 was $15.06M, a 5.79% increase year-over-year.
- Bausch Health Companies Inc. payments of ordinary dividends, common stock for the quarter ending 2010-06-30 was $14.26M, a 75.97% decline year-over-year.
- Bausch Health Companies Inc. payments of ordinary dividends, common stock for fiscal 2010 was $356.29M, a 142.13% increase from fiscal 2009.
- Bausch Health Companies Inc. payments of ordinary dividends, common stock for fiscal 2009 was $147.15M, a 18.38% decline from fiscal 2008.
- Bausch Health Companies Inc. payments of ordinary dividends, common stock for fiscal 2008 was $180.29M.
| Period end | Payments of Ordinary Dividends, Common Stock 3 month | Payments of Ordinary Dividends, Common Stock 6 month | Payments of Ordinary Dividends, Common Stock 9 month | Payments of Ordinary Dividends, Common Stock 12 month |
|---|---|---|---|---|
| 2011-06-30 | $0.00 10-Q · filed 2011-08-08 | |||
| 2010-12-31 | $312.73M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $327.79M derived: sum of 2 quarters · filed 2013-02-28 | $342.05M derived: sum of 3 quarters · filed 2013-02-28 | $356.29M 10-K · filed 2013-02-28 |
| 2010-09-30 | $15.06M 10-Q · filed 2011-11-04 | $29.32M derived: sum of 2 quarters · filed 2011-11-04 | $43.57M 10-Q · filed 2011-11-04 | $57.81M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $14.26M 10-Q · filed 2011-08-08 | $28.50M 10-Q · filed 2011-08-08 | $42.75M derived: sum of 3 quarters · filed 2012-02-29 | $56.99M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | $14.25M 10-Q · filed 2011-05-10 | $28.49M derived: sum of 2 quarters · filed 2012-02-29 | $42.73M derived: sum of 3 quarters · filed 2012-02-29 | $102.06M derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | $14.24M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $28.48M derived: sum of 2 quarters · filed 2012-02-29 | $87.81M derived: sum of 3 quarters · filed 2012-02-29 | $147.15M 10-K · filed 2012-02-29 |
| 2009-09-30 | $14.24M 10-Q · filed 2010-11-05 | $73.57M derived: sum of 2 quarters · filed 2010-11-05 | $132.90M 10-Q · filed 2010-11-05 | |
| 2009-06-30 | $59.33M 10-Q · filed 2010-08-06 | $118.66M 10-Q · filed 2010-08-06 | ||
| 2008-12-31 | $180.29M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |